Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$488K Buy
2,966
+139
+5% +$23.1K 0.04% 212
2024
Q4
$461K Sell
2,827
-174
-6% -$31.1K 0.03% 188
2024
Q3
$586K Buy
3,001
+313
+12% +$57.7K 0.04% 157
2024
Q2
$466K Buy
2,688
+178
+7% +$29.6K 0.04% 176
2024
Q1
$425K Buy
2,510
+68
+3% +$12.7K 0.04% 160
2023
Q4
$482K Buy
+2,442
New +$432K 0.05% 127
2022
Q1
Sell
-943
Closed -$230K 139
2021
Q4
$230K Buy
+943
New +$207K 0.03% 126

Other funds holding ZTS

Callan Capital's ZTS Position: Q1 2025 in Review

Callan Capital increased its Zoetis (ZTS) stake by 4.9% in Q1 2025, buying an estimated $23.1K and bringing the position to 2,966 shares worth $488K. The position accounts for 0.04% of the portfolio, ranked #212.

Callan Capital first reported a position in ZTS in Q4 2021 and has held it in 7 quarters since. The position peaked at $586K in Q3 2024. 1,889 funds tracked by Wall St. Rank hold ZTS as of Q1 2025.

  • Callan Capital held 2,966 shares of Zoetis worth $488K as of Q1 2025.
  • Callan Capital bought 139 Zoetis shares in Q1 2025, an estimated $23.1K.
  • Zoetis made up 0.04% of Callan Capital's portfolio in Q1 2025, its #212 holding.
  • Callan Capital first reported a position in Zoetis in Q4 2021 and has held it in 7 quarters since.
  • Callan Capital's Zoetis position peaked at $586K in Q3 2024.
  • 1,889 funds tracked by Wall St. Rank held Zoetis as of Q1 2025.

Based on Callan Capital's 13F filing for Q1 2025, filed 29 Apr 2025.